John D. Gaffen

470 total citations
17 papers, 317 citations indexed

About

John D. Gaffen is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, John D. Gaffen has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Rheumatology. Recurrent topics in John D. Gaffen's work include Osteoarthritis Treatment and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cell Adhesion Molecules Research (3 papers). John D. Gaffen is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cell Adhesion Molecules Research (3 papers). John D. Gaffen collaborates with scholars based in United Kingdom, Denmark and Canada. John D. Gaffen's co-authors include A. B. Bennett, Michael T. Bayliss, Roger M. Mason, J. Flannelly, Jayesh Dudhia, M.G. Chambers, I A Tavares, I F Stamford, Stacia Kargman and P K Weech and has published in prestigious journals such as Analytical Biochemistry, Gut and British Journal of Pharmacology.

In The Last Decade

John D. Gaffen

17 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Gaffen United Kingdom 11 122 94 83 52 51 17 317
Joseph Quintavalla United States 9 162 1.3× 153 1.6× 113 1.4× 45 0.9× 93 1.8× 11 497
Leandra Mfuna‐Endam Canada 6 142 1.2× 109 1.2× 158 1.9× 74 1.4× 39 0.8× 9 343
Lydia Barré France 12 90 0.7× 24 0.3× 185 2.2× 36 0.7× 50 1.0× 17 368
Dianming Jiang China 11 52 0.4× 38 0.4× 208 2.5× 55 1.1× 35 0.7× 16 348
Christian Patry Germany 10 33 0.3× 118 1.3× 123 1.5× 30 0.6× 35 0.7× 25 333
Taisei Masuda Japan 6 21 0.2× 97 1.0× 52 0.6× 19 0.4× 33 0.6× 10 404
Jean-Pierre Pelletier Canada 6 196 1.6× 119 1.3× 87 1.0× 22 0.4× 54 1.1× 11 347
Xiaohong Yang China 12 71 0.6× 54 0.6× 231 2.8× 57 1.1× 34 0.7× 21 381
Nadia Zayed Canada 8 181 1.5× 130 1.4× 229 2.8× 101 1.9× 18 0.4× 14 418
Samuel J. DiMari United States 11 23 0.2× 24 0.3× 185 2.2× 23 0.4× 32 0.6× 18 445

Countries citing papers authored by John D. Gaffen

Since Specialization
Citations

This map shows the geographic impact of John D. Gaffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Gaffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Gaffen more than expected).

Fields of papers citing papers by John D. Gaffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Gaffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Gaffen. The network helps show where John D. Gaffen may publish in the future.

Co-authorship network of co-authors of John D. Gaffen

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Gaffen. A scholar is included among the top collaborators of John D. Gaffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Gaffen. John D. Gaffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Spencer, John, John D. Gaffen, Elaine A. Harper, et al.. (2007). Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template. Bioorganic & Medicinal Chemistry. 16(6). 2974–2983. 20 indexed citations
2.
Mason, Roger M., M.G. Chambers, J. Flannelly, et al.. (2001). The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis and Cartilage. 9(2). 85–91. 109 indexed citations
3.
Gaffen, John D., Michael T. Bayliss, & Roger M. Mason. (1997). Elevated aggrecan mRNA in early murine osteoarthritis. Osteoarthritis and Cartilage. 5(4). 227–233. 8 indexed citations
4.
Gaffen, John D., P K Weech, Nathalie Tremblay, et al.. (1997). Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. European Journal of Cancer. 33(9). 1508–1512. 40 indexed citations
5.
Gaffen, John D., Michael T. Bayliss, & Roger M. Mason. (1997). OSTEOARTHRITIS and CARTILAGE Elevated aggrecan mRNA in early murine osteoarthritis. 1 indexed citations
6.
Gaffen, John D., et al.. (1995). Articular cartilage proteoglycans in osteoarthritic STR/Ort mice. Osteoarthritis and Cartilage. 3(2). 95–104. 19 indexed citations
7.
Gaffen, John D., Floyd M. Price, Michael T. Bayliss, & Roger M. Mason. (1994). A Ruthenium-103 Red Dot Blot Assay Specific for Nanogram Quantities of Sulfated Glycosaminoglycans. Analytical Biochemistry. 218(1). 124–130. 7 indexed citations
8.
Gaffen, John D.. (1992). INTERACTION BETWEEN THE CELL SURFACE AND THE EXTRACELLULAR MATRIX. Lara D. Veeken. 31(2). 74–76. 2 indexed citations
9.
Gaffen, John D., et al.. (1991). The Effect of Nifedipine Alone or Combined with Cytotoxic Chemotherapy on the Mouse NC Carcinoma In-vitro and In-vivo. Journal of Pharmacy and Pharmacology. 43(6). 401–405. 4 indexed citations
10.
Simopoulos, Constantinos, et al.. (1989). Effects of gastrointestinal hormones on the growth of human intestinal epithelial cells in vitro.. Gut. 30(5). 600–604. 12 indexed citations
11.
Gaffen, John D., et al.. (1989). The effects of dipyridamole and indomethacin on methotrexate cytotoxicity in LoVo human colon cancer cells. Journal of Pharmacy and Pharmacology. 41(5). 350–352. 10 indexed citations
12.
Bennett, A. B., et al.. (1987). Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate. British Journal of Pharmacology. 91(1). 229–235. 21 indexed citations
13.
Bennett, A. B., et al.. (1987). Indomethacin increases the cytotoxicity of methotrexate in vitro and in vivo.. PubMed. 17B. 986–8. 3 indexed citations
14.
Gaffen, John D., A. B. Bennett, & Michael R. Barer. (1985). A new method for studying cell growth in suspension, and its use to show that indomethacin enhances cell killing by methotrexate. Journal of Pharmacy and Pharmacology. 37(4). 261–263. 10 indexed citations
15.
Tavares, Ignatius A., A. B. Bennett, John D. Gaffen, Howard R. Morris, & Graham W. Taylor. (1984). The biological activities of phthalate esters on rat gastric muscle. European Journal of Pharmacology. 106(2). 449–452. 10 indexed citations
16.
Gaffen, John D., I A Tavares, & A. B. Bennett. (1984). The effect of garlic extracts on contractions of rat gastric fundus and human platelet aggregation. Journal of Pharmacy and Pharmacology. 36(4). 272–274. 20 indexed citations
17.
Chamberlain, M., et al.. (1980). In vitro biological effects of glass fibers.. PubMed. 2(6). 1369–83. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026